Suchergebnisse - "Satouchi, Miyako"

PubPharm (172)

1

Current Status and Issues of Companion Diagnostics for Non-Small Cell Lung Cancer

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2024

von Satouchi, M.

2

Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma : Results from the multicenter, phase 2 REMORA trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Niho, S. | Sato, J. | Satouchi, M. | +12

3

KEYNOTE-434 part B : A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer

enthalten in: Investigational new drugs | 2024

von Yamamoto, N. | Satouchi, M. | Doi, T. | +10

4

Five-Year Survival Outcomes After Carbon-Ion Radiotherapy for Operable Stage I NSCLC : A Japanese National Registry Study (J-CROS-LUNG)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Kubo, N. | Suefuji, H. | Nakajima, M. | +9

5

Brigatinib-related organizing pneumonia mimicking pulmonary infection

enthalten in: Japanese journal of clinical oncology | 2024

von Yasuda, Y. | Hattori, Y. | Sakuma, T. | +1

6

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer

enthalten in: Investigational new drugs | 2024

von Nogami, N. | Tokito, T. | Zenke, Y. | +7

7

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer

enthalten in: Investigational new drugs | 2024

von Nogami, N. | Tokito, T. | Zenke, Y. | +7

8

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab : Results from the Small Cell Lung Cancer Cohort

enthalten in: Cancer research communications | 2024

von Nishio, M. | Murakami, S. | Kawakami, H. | +17

9

Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer : The DOLPHIN Phase 2 Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2023

von Tachihara, M. | Tsujino, K. | Ishihara, T. | +15

10

Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

enthalten in: Heliyon | 2023

von Fukuda, K. | Katsurada, N. | Kawa, Y. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]